Deep learning in bioinformatics

S Min, B Lee, S Yoon - Briefings in bioinformatics, 2017 - academic.oup.com
In the era of big data, transformation of biomedical big data into valuable knowledge has
been one of the most important challenges in bioinformatics. Deep learning has advanced …

Machine learning in genomic medicine: a review of computational problems and data sets

MKK Leung, A Delong, B Alipanahi… - Proceedings of the …, 2015 - ieeexplore.ieee.org
In this paper, we provide an introduction to machine learning tasks that address important
problems in genomic medicine. One of the goals of genomic medicine is to determine how …

A sequence-based global map of regulatory activity for deciphering human genetics

KM Chen, AK Wong, OG Troyanskaya, J Zhou - Nature genetics, 2022 - nature.com
Epigenomic profiling has enabled large-scale identification of regulatory elements, yet we
still lack a systematic mapping from any sequence or variant to regulatory activities. We …

Predicting the sequence specificities of DNA-and RNA-binding proteins by deep learning

B Alipanahi, A Delong, MT Weirauch, BJ Frey - Nature biotechnology, 2015 - nature.com
Knowing the sequence specificities of DNA-and RNA-binding proteins is essential for
developing models of the regulatory processes in biological systems and for identifying …

Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution

M Kircher, C Xiong, B Martin, M Schubach… - Nature …, 2019 - nature.com
The majority of common variants associated with common diseases, as well as an unknown
proportion of causal mutations for rare diseases, fall in noncoding regions of the genome …

Interpretation of deep learning in genomics and epigenomics

A Talukder, C Barham, X Li, H Hu - Briefings in Bioinformatics, 2021 - academic.oup.com
Abstract Machine learning methods have been widely applied to big data analysis in
genomics and epigenomics research. Although accuracy and efficiency are common goals …

Molecular characterization of familial hypercholesterolemia in Spain

L Palacios, L Grandoso, N Cuevas, E Olano-Martín… - Atherosclerosis, 2012 - Elsevier
Familial hypercholesterolemia (FH), characterized by isolated elevation of plasmatic low-
density lipoprotein (LDL) cholesterol and premature coronary heart disease (CHD), is …

Genetics of familial hypercholesterolemia

A Brautbar, E Leary, K Rasmussen, DP Wilson… - Current atherosclerosis …, 2015 - Springer
Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated low-
density lipoprotein (LDL) cholesterol and premature cardiovascular disease, with a …

Measuring pharmacogene variant function at scale using multiplexed assays

RC Geck, G Boyle, CJ Amorosi… - Annual Review of …, 2022 - annualreviews.org
As costs of next-generation sequencing decrease, identification of genetic variants has far
outpaced our ability to understand their functional consequences. This lack of understanding …

Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas …

J Caron, V Pène, L Tolosa, M Villaret, E Luce… - Stem Cell Research & …, 2019 - Springer
Background Familial hypercholesterolemia type IIA (FH) is due to mutations in the low-
density lipoprotein receptor (LDLR) resulting in elevated levels of low-density lipoprotein …